July 2012

'Debate closed': JAMA study finds endoscopic vein harvesting safe ()
Weekend care for a-fib can lead to higher mortality ()
mHealth Congress: Joslin goes virtual for diabetes management ()
Hospitals implement only half of key AMI, HF practices ()
Covidien sees slight jump in Q3 sales, income ()
FDA approves omega-3 fatty acid drug for very high triglycerides ()
Cost-cutting Strategies that Deliver: Three Solutions for the Cath Lab ()
Putting Politics Aside for Progress ()
In the News | Surgery ()
Anatomy of a Successful Hybrid OR ()
Novel Views of Vulnerable Plaque ()
ACC Corner | Debunking the AUC Myths ()
MedAxiom Takes the Windy City by Storm ()
FFR 2.0: A Calculated Run for Supremacy ()
Survey: 45% of cardiologists ditching medicine in next 10 years ()
Edwards strides through Q2 due to strong transcatheter valve sales ()
XCELL finds infrapopliteal nitinol stenting safe, effective for CLI ()
Roubin leaves Lenox Hill for Continuum ()
Imaging may extend golden window for stroke treatment ()
Circ: Radial approach can save hospitals $275 per patient ()
Acute MI risk raised two weeks after total hip or knee replacement surgeries ()
Today's quandary: Better survival, sicker patients ()
St. Jude stays above water in Q2, despite drop in sales ()
Can a polypill a day keep heart disease at bay? ()
Western providers largely missing from U.S. News top-ranked heart hospitals ()
JAMA feature: Adding stroke severity improves accuracy of hospital rankings ()
Astra to study ticagrelor in PAD patients ()
JACC: Real-world results lean in favor of stenting left main coronary artery ()
Cleveland Clinics Marwick heads back Down Under ()
Multisocietal update adds ticagrelor to NSTEMI guidelines ()
Choosing among warfarins alternatives may be easier ()
Circ: Stroke outcomes better when EMS notifies hospital ()
At 3.5 years, apixaban beats aspirin for cost-effectiveness ()
Acadesine doesn't help improve outcomes post-CABG ()
Pfizer plans to challenge retailers suit over Lipitor tactics ()
Feature: Many readmissions after heart attack not due to index MI ()
Feature: Looking to transform costs? Start with DES use ()
NEJM: Delirium post-CABG leads to drop in cognitive function ()
GSK's $3 billion settlement includes Avandia count ()
Bristol-Myers Squibb buys Amylin for $5.3B plus debt ()